Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 50,000 shares of the firm’s stock in a transaction dated Wednesday, October 8th. The shares were sold at an average price of $13.07, for a total transaction of $653,500.00. Following the completion of the transaction, the chief executive officer directly owned 9,689,071 shares in the company, valued at $126,636,157.97. This trade represents a 0.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
K Charles Janac also recently made the following trade(s):
- On Monday, October 6th, K Charles Janac sold 100,000 shares of Arteris stock. The shares were sold at an average price of $13.10, for a total transaction of $1,310,000.00.
- On Monday, October 6th, K Charles Janac sold 5,755 shares of Arteris stock. The shares were sold at an average price of $14.00, for a total transaction of $80,570.00.
- On Friday, October 3rd, K Charles Janac sold 11,821 shares of Arteris stock. The shares were sold at an average price of $11.07, for a total transaction of $130,858.47.
- On Thursday, October 2nd, K Charles Janac sold 7,147 shares of Arteris stock. The shares were sold at an average price of $10.92, for a total transaction of $78,045.24.
- On Thursday, September 4th, K Charles Janac sold 2,057 shares of Arteris stock. The shares were sold at an average price of $8.73, for a total transaction of $17,957.61.
- On Tuesday, September 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The shares were sold at an average price of $8.94, for a total transaction of $11,139.24.
- On Tuesday, August 5th, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.12, for a total transaction of $656,000.00.
- On Tuesday, August 5th, K Charles Janac sold 94,245 shares of Arteris stock. The shares were sold at an average price of $13.49, for a total transaction of $1,271,365.05.
Arteris Stock Performance
Shares of NASDAQ AIP opened at $12.39 on Friday. The stock has a market cap of $528.43 million, a P/E ratio of -15.11 and a beta of 1.45. The firm has a 50 day moving average price of $9.98 and a 200 day moving average price of $8.60. Arteris, Inc. has a 52-week low of $5.46 and a 52-week high of $14.58.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on AIP shares. TD Cowen lifted their price target on shares of Arteris from $12.00 to $15.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Wall Street Zen raised shares of Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research note on Wednesday. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $15.00.
Read Our Latest Stock Report on AIP
Institutional Trading of Arteris
Institutional investors have recently made changes to their positions in the business. Raymond James Financial Inc. bought a new stake in shares of Arteris in the second quarter worth $32,000. CWM LLC lifted its position in shares of Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company’s stock worth $71,000 after purchasing an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. bought a new stake in shares of Arteris in the first quarter worth $95,000. Savant Capital LLC bought a new stake in shares of Arteris in the second quarter worth $97,000. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of Arteris in the second quarter worth $104,000. Institutional investors own 64.36% of the company’s stock.
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles
- Five stocks we like better than Arteris
- What is the FTSE 100 index?
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Investing In Preferred Stock vs. Common Stock
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- How to Invest in Biotech Stocks
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.